Mukka Proteins Receives Bond Enforcement Order from Customs; Faces ₹7.67 Crore Duty Demand
Mukka Proteins received a Bond Enforcement Order from Customs demanding ₹7.67 Crore plus applicable interest. This relates to duty-free imports under Advance Licences where export obligations were allegedly not met. The company is reviewing the order and considering legal remedies.
The demand of ₹7.67 Crore, while significant, is not expected to have a material impact on the company's overall operations or financials, as stated in the announcement. However, it represents a notable financial obligation.
The company has received a demand for payment of customs duty along with interest, which is a negative financial event.
Mukka Proteins Limited has received a Bond Enforcement Order from the Office of the Commissioner of Customs, Mangaluru, dated December 29, 2025.
The order pertains to Advance Licences issued by DGFT, under which the company had made duty-free imports. The Customs department alleges non-submission of evidence for fulfilling export obligations and not furnishing the Export Obligation Discharge Certificate (EODC) within the stipulated timelines.
Consequently, the Customs has enforced the bonds executed by the company and ordered the recovery of customs duty debited therein, along with applicable interest. The total customs duty amount demanded is ₹7,67,03,840 (Rupees Seven Crore Sixty-Seven Lakh Three Thousand Eight Hundred Forty only).
The company is currently examining the order and evaluating its available legal remedies, including the submission of necessary documents. Apart from the mentioned duty amount and interest, there is no other expected financial implication or operational impact on the company.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.